Mihai Surcel

ORCID: 0000-0003-4922-3013 · 11 papers in corpus
observational 2026
Medicina (Kaunas, Lithuania) ·doi:10.3390/medicina62030571

Background and Objectives: Adenomyosis is increasingly being recognized as a heterogeneous uterine disorder with variable clinical expressions. Current ultrasound-based classifications do not consistently align structural severity with symp…

case-report 2026
Diagnostics (Basel, Switzerland) ·doi:10.3390/diagnostics16010134

Background and Clinical Significance: Pelvic inflammatory disease represents a multifaceted sexually transmitted disease affecting women of reproductive age, beginning in adolescence. Clinical presentation ranges from asymptomatic patients …

other 2025
Genes ·doi:10.3390/genes16050537

Background/Objectives: Infertility is a reproductive disorder affecting approximately 10-15% of reproductive-age couples worldwide. Recent studies have suggested that miRNAs in follicular fluid may provide insights into reproductive potenti…

other 2025
International journal of molecular sciences ·doi:10.3390/ijms26157367

Recurrent implantation failure (RIF) remains a challenging clinical problem. Growth hormone (GH) co-treatment has been explored as an adjunct in poor responders and RIF patients, with inconsistent evidence of benefit. This prospective cohor…

case-report 2025
Diagnostics ·doi:10.3390/diagnostics15233018

The potential concurrence of uterine leiomyoma and adenomyosis has been mentioned in several studies to date, but as co-existing entities, not as a sequence of pathologic events. This is the case of a young 31-year-old nulliparous patient p…

observational 2025
Diagnostics (Basel, Switzerland) ·doi:10.3390/diagnostics15070868

Background: Vascular Endothelial Growth Factor (VEGF) is a key regulator in angiogenesis and contributes to a successful implantation. The current study has the following objective: to perform genotyping and haplotyping analysis to confirm …

observational 2023
Diagnostics (Basel, Switzerland) ·doi:10.3390/diagnostics13193048

A growing body of evidence suggests that endometrial immune disorders may be responsible for endometrial dysfunctions that can lead to gynecological and obstetrical pathology. The aim of this study was to explore the potential relationship …

other 2022
Diagnostics (Basel, Switzerland) ·doi:10.3390/diagnostics12102371

“Poor responders” (PR) are an important category of infertile women who experience a modest response to controlled ovarian stimulation. In this study, we evaluated response to growth hormone (GH) administration among PR patient subtypes str…

observational 2022
PeerJ ·doi:10.7717/peerj.14189

BACKGROUND: Infertility is an important health concern worldwide. Although lifestyle habits and behaviors have been widely reported as predictors of IVF outcomes by previous studies, they have not been reported for Romanian women undergoing…

review 2020

Adenomyosis is a benign condition that belongs to a group of estrogen-dependent disorders associated with significant clinical consequences: dysmenorrhea, menorrhagia, and infertility. Recent data concerning the pathogenesis of adenomyosis …

review 2020
·doi:10.26416/obsgin.68.2.3855

Adenomyosis is a benign condition that belongs to a group of estrogen-dependent disorders associated with significant clinical consequences: dysmenorrhea, menorrhagia, and infertility. Recent data concerning the pathogenesis of adenomyosis …